The data that high frequency of IDH1 and TP53 mutation are already present in AII and the frequency does not increase (even decrease) in AIII suggests that they might be not associated with malignant progression of astrocytomas, especially in progression from AII to AIII. The gene discussed is IDH1; the disease is astrocytoma (excluding glioblastoma).